Results 51 to 60 of about 19,999 (193)
Thrombopoietin level in patients with chronic liver diseases
Annals of Hepatology, 2008 Thrombocytopenia and oxidative stress are the most frequent problems in patients with chronic liver diseases as viral cirrhosis and schistosomiasis. So, this study aimed to evaluate the role of thrombopoietin (TPO) on the occurrence of thrombocytopenia ...
Laila A. Eissa +3 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
Journal of Clinical Laboratory Analysis, EarlyView.In this post‐transplant patient, increased hyaline casts with negative dipstick protein but positive SSA testing occurred during evolving acute kidney injury and resolved with renal recovery. This discordant urinalysis pattern may warrant confirmatory protein testing and correlation with serial renal function in patients at high risk of AKI.
Yifei Jia +6 more
wiley +1 more source
Veterinary Record, EarlyView.Abstract Background Hepatocellular carcinoma (HCC) is the most common canine hepatobiliary tumour. This study aimed to determine which criteria influenced outcome of HCC in a modern population of dogs across eight institutions. Methods The medical records of 106 dogs with HCC were retrospectively reviewed.
Emily A. Janik +2 more
wiley +1 more source
Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia [PDF]
, 2023 Thrombopoietin receptor agonists are commonly second-line drugs in immune thrombocytopenia (ITP) pharmacotherapy in children and prescribed for chronic ITP refractory to first-line ...
Vorobieva, V. V. +4 more
core
ANZ Journal of Surgery, EarlyView.Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett +9 more
wiley +1 more source
Regulation of thrombopoietin in bone marrow [PDF]
, 2007 The normal elimination of a large number of circulating hematopoietic cells from the circulation each day necessitates substantial proliferation and maturation of progenitor cells in bone marrow.
McIntosh, Bryan James
core
Thrombopoietin-Induced Signal Transduction and Potentiation of Platelet Activation
, 1999 IntroductionThe presence of thrombopoietin, a humoral regulator of megakaryopoiesis and thrombopoiesis, had been suggested for years,1 however, some investigators were skeptical about the existence of such a factor. Modern studies of thrombopoietin begin
Yoshitaka Miyakawa +9 more
core +1 more source
British Journal of Haematology, EarlyView.Summary Patients with immune thrombocytopenia (ITP) exhibit substantial heterogeneity in treatment responses. Approximately 30%–50% of patients maintain remission after discontinuation of thrombopoietin receptor agonists (TPO‐RA), suggesting immunomodulatory effects beyond enhanced thrombopoiesis.
Vivianne S. Nelson +5 more
wiley +1 more source
Idiopathic thrombocytopenic purpura: laboratory diagnosis and management [PDF]
Universa Medicina, 2011 Idiopathic thrombocytopenic purpura (ITP) or immune thrombocytopenic purpura is a disease characterized by low platelet count (
Alvina
doaj